Model for Lung Repair

​Ground-breaking model for lung repair research and trials

Imperial’s Lung Development and Repair Group has devised a highly effective model to track lung repair to support drug development and academic research.

Their AIR Model (Acid Injury Repair) combines the accessibility of ex-vivo study with the accuracy of working with living tissue.

Using this model, the group can deliver:

  • Bespoke studies of small molecules and growth factors to drive repair
  • Drug testing from pre-clinical models to phase II, first-in-man trials
  • Real-time imaging to track cell behaviour in damaged tissue
  • Consultancy and training to establish the model in client labs and facilities

They can support all levels of biotech and pharmaceutical product development, as well as offering unprecedented depth of observation for academic research.

 

Accuracy of in-vivo research with flexibility of ex-vivo material.

This highly reproducible procedure allows researchers to subject an isolated area of a living lung slice to acid damage, then observe the tissue repair process under a range of conditions.

Unlike traditional organoid-based research, the AIR model preserves the full structure of living tissue – and bridges the historic disconnect between lab work and clinical trials.

It can be run on both animal and human samples at a semi-high throughput scale; and includes a real-time imaging solution, deploying fluorescent tags to enable deep observation at a cellular and sub-cellular level – previously impossible with living tissue.

AIR Model samples also preserve tissue-resident macrophages, offering an indication of immune response that is often unavailable in organoids.

 

Leading Regenerative Medicine Lab

The Lung Development and Repair Group is a multi-disciplinary team of clinicians and researchers with an international reputation, experienced in working with a range of in vivo and ex vivo models across animal and human subjects.

The team can deliver a full development process from pre-clinical models to clinical trials, whilst Dr Sek-Shir Cheong can also consult on its application other settings, including other areas of regenerative medicine.

“The AIR Model has allowed us to work with much greater control at all levels of drug development and research – whether we’re looking to affect signalling pathways, searching for new pro-repair factors or simply following cell behaviour in damaged tissue. We’re excited to apply it in support of clients and partners in industry and wider research fields.” Group Head Dr Charlotte Dean

 

Click here to read more about the team, the AIR model and their work… 

Including: real-time imaging of lung slices

 

Current projects:

And Publication: The acid injury and repair (AIR) model: A novel ex-vivo tool to understand lung repair

Our consultants are world-leading experts in their field, committed to on-going research and innovation, and here to help with your challenges. 

Related Insights

Life after lockdown: Health and healthcare

Life after lockdown: Health and healthcare

As the first volunteer receives Imperial’s COVID-19 vaccine – academics from across Imperial are working on solutions to take us past the pandemic into life after lockdown. read more

Life after lockdown: COVID-19 response

Life after lockdown: COVID-19 response

Imperial's experts, from a wide range of disciplines, have and continue to keep us informed about COVID-19 and the coronavirus response, save lives through vaccines and testing - and provide solutions to protect the NHS. read more

Related case studies

Imperial College London Diabetes Centre

Imperial College London Diabetes Centre

The Imperial College London Diabetes Centre was established in Abu Dhabi, in 2006, by Mubadala and experts from Imperial to address the demand for diabetes care in the UAE. With continued support from Imperial, the centre now operates three branches across Abu Dhabi and Al Ain and public health initiatives. read more

Cystic Fibrosis clinical advisory board

Cystic Fibrosis clinical advisory board

Our consultants shared their expertise in Cystic Fibrosis (CF), drug development and clinical trials to help Proteostasis Therapeutics assess the combination of compounds aimed at treatments to improve lung function. read more

Global adoption and regulation of electronic medical records

Global adoption and regulation of electronic medical records

Our consultants shared their expertise in clinical medicine to help IMS Health to assess the adoption, governance and regulatory landscape of electronic medical records (EMR) at different levels of healthcare systems around the world. read more

Latest news

Tackling London’s air pollution will increase life expectancy of children

Tackling London’s air pollution will increase life expectancy of children

Report by researchers from Environmental Research Group predicts London air quality policies, and wider improvements in air quality, will increase average life expectancy of a child born in London in 2013 by six months. read more

Electric Insights – quarterly reports

Electric Insights – quarterly reports

Commissioned by Drax and delivered by Dr Iain Staffell and team, the quarterly Electric Insights reports analyse raw data made publicly available by National Grid and Elexon, which run the electricity and balancing market respectively, and Sheffield Solar. read more

Cricketer set a £1million batting challenge

Cricketer set a £1million batting challenge

A leading cricketer has been offered £1million to strike a ball clear of the Lord’s Pavilion, using a new Mongoose bat tested by Imperial Consultants. read more